SRPT logo

Sarepta Therapeutics (SRPT) Accounts payable

annual accounts payable:

$214.44M+$49.52M(+30.03%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual accounts payable is $214.44 million, with the most recent change of +$49.52 million (+30.03%) on December 31, 2024.
  • During the last 3 years, SRPT annual accounts payable has risen by +$137.70 million (+179.44%).
  • SRPT annual accounts payable is now at all-time high.

Performance

SRPT Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly accounts payable:

$156.10M-$58.34M(-27.20%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly accounts payable is $156.10 million, with the most recent change of -$58.34 million (-27.20%) on March 1, 2025.
  • Over the past year, SRPT quarterly accounts payable has increased by +$64.57 million (+70.54%).
  • SRPT quarterly accounts payable is now -27.20% below its all-time high of $214.44 million, reached on December 31, 2024.

Performance

SRPT quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

SRPT Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+30.0%+70.5%
3 y3 years+179.4%+189.1%
5 y5 years+214.9%+487.0%

SRPT Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+179.4%-27.2%+189.1%
5 y5-yearat high+214.9%-27.2%+487.0%
alltimeall timeat high>+9999.0%-27.2%>+9999.0%

SRPT Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$156.10M(-27.2%)
Dec 2024
$214.44M(+30.0%)
$214.44M(+80.5%)
Sep 2024
-
$118.77M(+10.6%)
Jun 2024
-
$107.42M(+17.3%)
Mar 2024
-
$91.54M(-44.5%)
Dec 2023
$164.92M(+72.0%)
$164.92M(+87.5%)
Sep 2023
-
$87.95M(-19.9%)
Jun 2023
-
$109.80M(+2.9%)
Mar 2023
-
$106.71M(+11.3%)
Dec 2022
$95.88M(+24.9%)
$95.88M(-19.1%)
Sep 2022
-
$118.46M(+110.8%)
Jun 2022
-
$56.21M(+4.1%)
Mar 2022
-
$54.01M(-29.6%)
Dec 2021
$76.74M(-30.9%)
$76.74M(+73.8%)
Sep 2021
-
$44.16M(-42.4%)
Jun 2021
-
$76.68M(+0.0%)
Mar 2021
-
$76.65M(-31.0%)
Dec 2020
$111.09M(+63.1%)
$111.09M(+49.1%)
Sep 2020
-
$74.53M(-18.7%)
Jun 2020
-
$91.66M(+244.7%)
Mar 2020
-
$26.59M(-60.9%)
Dec 2019
$68.09M(+101.3%)
$68.09M(-16.9%)
Sep 2019
-
$81.95M(+86.1%)
Jun 2019
-
$44.05M(+66.2%)
Mar 2019
-
$26.50M(-21.7%)
Dec 2018
$33.83M(+299.5%)
$33.83M(+65.8%)
Sep 2018
-
$20.41M(+17.4%)
Jun 2018
-
$17.38M(+0.0%)
Mar 2018
-
$17.38M(+105.3%)
Dec 2017
$8.47M(-71.5%)
$8.47M(+59.2%)
Sep 2017
-
$5.32M(-51.3%)
Jun 2017
-
$10.92M(-60.2%)
Mar 2017
-
$27.45M(-7.6%)
Dec 2016
$29.69M(+46.7%)
$29.69M(+43.5%)
Sep 2016
-
$20.68M(+20.7%)
Jun 2016
-
$17.13M(-8.2%)
Mar 2016
-
$18.67M(-7.7%)
Dec 2015
$20.23M(+63.1%)
$20.23M(+172.3%)
Sep 2015
-
$7.43M(-47.3%)
Jun 2015
-
$14.10M(+51.3%)
Mar 2015
-
$9.32M(-24.9%)
Dec 2014
$12.41M(+53.6%)
$12.41M(+1183.1%)
Sep 2014
-
$967.00K(-26.1%)
Jun 2014
-
$1.31M(-83.0%)
Mar 2014
-
$7.72M(-4.4%)
Dec 2013
$8.08M(+7.3%)
$8.08M(-0.6%)
Sep 2013
-
$8.13M(+20.8%)
Jun 2013
-
$6.73M(-4.9%)
Mar 2013
-
$7.07M(-6.1%)
Dec 2012
$7.53M(-19.8%)
$7.53M(+73.8%)
Sep 2012
-
$4.33M(-50.8%)
Jun 2012
-
$8.81M(+7.5%)
Mar 2012
-
$8.20M(-12.8%)
Dec 2011
$9.40M(+616.7%)
$9.40M(+19.0%)
Sep 2011
-
$7.90M(-28.0%)
Jun 2011
-
$10.97M(+69.3%)
Mar 2011
-
$6.48M(+394.6%)
DateAnnualQuarterly
Dec 2010
$1.31M(-5.1%)
$1.31M(-73.5%)
Sep 2010
-
$4.95M(+108.7%)
Jun 2010
-
$2.37M(+34.5%)
Mar 2010
-
$1.76M(+27.5%)
Dec 2009
$1.38M(-31.4%)
$1.38M(-67.9%)
Sep 2009
-
$4.30M(+185.7%)
Jun 2009
-
$1.51M(+17.7%)
Mar 2009
-
$1.28M(-36.5%)
Dec 2008
$2.01M(-33.4%)
$2.01M(-38.2%)
Sep 2008
-
$3.26M(+40.1%)
Jun 2008
-
$2.33M(-31.0%)
Mar 2008
-
$3.37M(+11.3%)
Dec 2007
$3.03M(+115.9%)
$3.03M(-42.6%)
Sep 2007
-
$5.27M(+124.6%)
Jun 2007
-
$2.35M(+24.3%)
Mar 2007
-
$1.89M(+34.8%)
Dec 2006
$1.40M(-24.7%)
$1.40M(+21.2%)
Sep 2006
-
$1.16M(-10.3%)
Jun 2006
-
$1.29M(+3.0%)
Mar 2006
-
$1.25M(-32.8%)
Dec 2005
$1.86M(+27.8%)
$1.86M(+13.4%)
Sep 2005
-
$1.64M(+30.6%)
Jun 2005
-
$1.26M(-20.2%)
Mar 2005
-
$1.57M(+8.1%)
Dec 2004
$1.46M(-52.3%)
$1.46M(+97.6%)
Sep 2004
-
$737.10K(-54.2%)
Jun 2004
-
$1.61M(-9.7%)
Mar 2004
-
$1.78M(-41.6%)
Dec 2003
$3.05M(-32.8%)
$3.05M(+67.9%)
Sep 2003
-
$1.82M(+124.3%)
Jun 2003
-
$810.90K(-28.2%)
Mar 2003
-
$1.13M(-75.1%)
Dec 2002
$4.54M(+63.8%)
$4.54M(+1.6%)
Sep 2002
-
$4.47M(+25.8%)
Jun 2002
-
$3.55M(-16.4%)
Mar 2002
-
$4.25M(+53.2%)
Dec 2001
$2.77M(+114.8%)
$2.77M(+141.1%)
Sep 2001
-
$1.15M(-7.6%)
Jun 2001
-
$1.25M(+2.3%)
Mar 2001
-
$1.22M(-5.7%)
Dec 2000
$1.29M(+84.4%)
$1.29M(+27.3%)
Sep 2000
-
$1.01M(+20.8%)
Jun 2000
-
$839.30K(+64.6%)
Mar 2000
-
$509.90K(-27.2%)
Dec 1999
$700.00K(-22.2%)
$700.00K(+75.0%)
Sep 1999
-
$400.00K(+100.0%)
Jun 1999
-
$200.00K(-60.0%)
Mar 1999
-
$500.00K(-44.4%)
Dec 1998
$900.00K(+350.0%)
$900.00K(0.0%)
Sep 1998
-
$900.00K(+125.0%)
Jun 1998
-
$400.00K(+33.3%)
Mar 1998
-
$300.00K(+50.0%)
Dec 1997
$200.00K(0.0%)
$200.00K(-60.0%)
Sep 1997
-
$500.00K(0.0%)
Jun 1997
-
$500.00K(+150.0%)
Mar 1997
-
$200.00K
Dec 1996
$200.00K
-

FAQ

  • What is Sarepta Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual accounts payable year-on-year change?
  • What is Sarepta Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly accounts payable year-on-year change?

What is Sarepta Therapeutics annual accounts payable?

The current annual accounts payable of SRPT is $214.44M

What is the all time high annual accounts payable for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual accounts payable is $214.44M

What is Sarepta Therapeutics annual accounts payable year-on-year change?

Over the past year, SRPT annual accounts payable has changed by +$49.52M (+30.03%)

What is Sarepta Therapeutics quarterly accounts payable?

The current quarterly accounts payable of SRPT is $156.10M

What is the all time high quarterly accounts payable for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly accounts payable is $214.44M

What is Sarepta Therapeutics quarterly accounts payable year-on-year change?

Over the past year, SRPT quarterly accounts payable has changed by +$64.57M (+70.54%)
On this page